First Trust Advisors LP Novartis Ag Transaction History

First Trust Advisors LP

  • $95 Billion
  • Q2 2024

A detailed history of First Trust Advisors LP transactions in Novartis Ag stock. As of the latest transaction made, First Trust Advisors LP holds 467,516 shares of NVS stock, worth $51.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
467,516
Previous 629,247 25.7%
Holding current value
$51.7 Million
Previous $60.9 Million 18.23%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $15 Million - $17.4 Million
-161,731 Reduced 25.7%
467,516 $49.8 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $4.71 Million - $5.36 Million
-49,427 Reduced 7.28%
629,247 $60.9 Million
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $726,164 - $799,119
7,870 Added 1.17%
678,674 $68.5 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $3.8 Million - $4.21 Million
-40,081 Reduced 5.64%
670,804 $68.3 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $8.83 Million - $10 Million
-95,432 Reduced 11.84%
710,885 $71.7 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $1.04 Million - $1.2 Million
12,937 Added 1.63%
806,317 $74.2 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $6.69 Million - $8.19 Million
-88,494 Reduced 10.03%
793,380 $72 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $12 Million - $14 Million
160,685 Added 22.28%
881,874 $67 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $796,584 - $927,468
9,893 Added 1.39%
721,189 $61 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $176,081 - $199,182
2,198 Added 0.31%
711,296 $62.4 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $253,764 - $280,605
-3,184 Reduced 0.45%
709,098 $62 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $7.13 Million - $8.29 Million
87,184 Added 13.95%
712,282 $58.3 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $3.89 Million - $4.3 Million
-45,660 Reduced 6.81%
625,098 $57 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $5.3 Million - $6.25 Million
63,426 Added 10.44%
670,758 $57.3 Million
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $1.73 Million - $2.09 Million
22,184 Added 3.79%
607,332 $57.4 Million
Q3 2020

Nov 05, 2020
BUY
$82.14 - $91.0 $6.15 Million - $6.81 Million
74,890 Added 14.68%
585,148 $50.9 Million
Q2 2020

Jul 22, 2020
BUY
$80.93 - $91.1 $2.8 Million - $3.15 Million
34,565 Added 7.27%
510,258 $44.6 Million
Q1 2020

May 06, 2020
SELL
$70.67 - $99.01 $2.89 Million - $4.04 Million
-40,826 Reduced 7.9%
475,693 $39.2 Million
Q4 2019

Feb 03, 2020
BUY
$84.35 - $95.37 $1.57 Million - $1.77 Million
18,559 Added 3.73%
516,519 $48.9 Million
Q3 2019

Nov 04, 2019
BUY
$85.54 - $94.26 $10.6 Million - $11.7 Million
124,154 Added 33.21%
497,960 $43.3 Million
Q2 2019

Jul 30, 2019
BUY
$75.4 - $92.8 $27.7 Million - $34.1 Million
367,679 Added 6000.96%
373,806 $34.1 Million
Q1 2019

May 09, 2019
SELL
$75.32 - $86.15 $20.8 Million - $23.8 Million
-276,478 Reduced 97.83%
6,127 $589,000
Q4 2018

Feb 07, 2019
BUY
$73.66 - $82.02 $453,156 - $504,587
6,152 Added 2.23%
282,605 $24.3 Million
Q3 2018

Oct 25, 2018
SELL
$66.94 - $77.43 $2.22 Million - $2.57 Million
-33,175 Reduced 10.71%
276,453 $23.8 Million
Q2 2018

Aug 02, 2018
BUY
$64.91 - $73.36 $3.09 Million - $3.49 Million
47,618 Added 18.17%
309,628 $23.4 Million
Q1 2018

Apr 23, 2018
SELL
$70.39 - $84.15 $174,778 - $208,944
-2,483 Reduced 0.94%
262,010 $21.2 Million
Q4 2017

Feb 08, 2018
BUY
$72.33 - $77.64 $2.32 Million - $2.49 Million
32,070 Added 13.8%
264,493 $22.2 Million
Q3 2017

Oct 24, 2017
BUY
$74.14 - $77.27 $17.2 Million - $18 Million
232,423
232,423 $20 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email